Dr. Alexa Albert on Treating Narcissism with MDMA

In the first interview episode of The Psychonaut Show, hosts Dr. John and Dr. Tracy welcome Dr. Alexa Albert. Dr. Alexa’s clinical work focuses on the enduring psychological patterns shaped by early relational trauma, particularly pathological narcissism. This episode centers on Dr. Alexa’s groundbreaking work leading the first clinical trial to investigate MDMA-assisted psychotherapy for pathological narcissism. Dr. Alexa discusses the importance of integrating psychedelic treatment with psychotherapy, and how psychoanalytic therapy is particularly suited to this work. She explains why models that separate medicine from sustained therapeutic relationships risk leaving patients emotionally exposed without adequate support. For individuals with narcissistic defenses, she argues, the therapeutic alliance itself is central. MDMA, in her view, does not replace the work of therapy but enhances it. Dr. Alexa addresses common misconceptions about narcissism, reframing it not as excessive self-love but as a condition rooted in profound feelings of unworthiness, invisibility, and unmet relational needs. She describes how narcissistic defenses develop as adaptive responses to unsafe early environments and how MDMA-assisted therapy may help patients access buried vulnerability and foster profound relational openness, experiences that would otherwise take years to reach in conventional psychoanalysis. She weaves together psychoanalysis, trauma theory, and psychedelic science, offering a thoughtful and humane vision for how these medicines might expand the possibilities of deep psychological healing. Episode Links:- Alexa Albert's website https://www.alexaalbert.com/- Information on Dr. Alexa's current pilot study for treating pathological narcissism with MDMA-assisted therapy https://depts.washington.edu/mdma-narcissism/- Dr. Alexa's co-authored paper providing the rationale for MDMA-assisted therapy as an appropriate, targeted treatment for pathological narcissism https://www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2025.1529427/full